Itamar Medical’s WatchPAT300 OK'd in Japan

Itamar Medical(NASDAQ:ITMR)announces that its flagship WatchPAT300 Home Sleep Apnea Testing (HSAT) device has been granted PMDA approval for use in the Japanese market, effective September 14, 2020.

The WatchPAT300 will be made available in Japan through Philips Japan Co., ITMR's exclusive Japanese distributor.

FDA-approved WatchPAT is used for diagnosing Sleep Apnea at patients home.

Click to subscribe to real-time analytics on ITMR

Now read:Beam Therapeutics prices equity offering at $23.50 »